Can work out of Princeton, NJ or Rockville, MD office.
Actively participates and contributes to the study design and reporting of Clinical Pharmacology studies. Provides input into all phases of drug development including, but not limited to, dose finding, dose optimization, exposure-response and pediatric development. Closely interacts with nonclinical and bioanalytical team members for design and execution of first-in-human, mass balance and drug interaction studies. Author of Clinical Pharmacology submission documents and representative of the department at different product development team meetings. Works closely with Pharmacometrics and Simulation and Modeling team members to provide input on modeling and simulation activities.
Required education and experience
Otsuka Pharmaceutical Company is a global healthcare company with the corporate philosophy: “Otsuka-people creating new products for better health worldwide.” Otsuka researches, develops, manufactures and markets innovative products, with a focus on pharmaceutical products to meet unmet medical needs and nutraceutical products for the maintenance of everyday health.
In pharmaceuticals, Otsuka is a leader in the challenging area of mental health and also has research programs on several under-addressed diseases including tuberculosis, a significant global public health issue. These commitments illustrate how Otsuka is a “big venture” company at heart, applying a youthful spirit of creativity in everything it does.
Otsuka Pharmaceutical Company is a subsidiary of Otsuka Holdings Co., Ltd. headquartered in Tokyo, Japan. The Otsuka group of companies employed 45,000 people worldwide and had consolidated sales of approximately USD 11 billion (€ 9.9 billion) in 2016.
All Otsuka stories start by taking the road less travelled. Learn more about Otsuka Pharmaceutical Company on its global website at www.otsuka.co.jp/en. Learn more about Otsuka in the U.S. at www.otsuka-us.com.